Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 4/2014

01-12-2014 | Original Article

Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients

Authors: Tsuyoshi Ohkura, Youhei Fujioka, Shoichiro Izawa, Keisuke Sumi, Naoya Yamamoto, Hideki Shiochi, Kazuhiko Matsuzawa, Hiroshi Kinoshita, Hiroko Ohkura, Masahiko Kato, Shin-Ichi Taniguchi, Kazuhiro Yamamoto

Published in: International Journal of Diabetes in Developing Countries | Issue 4/2014

Login to get access

Abstract

Several studies report that endogenous insulin secretion (EIS) ability is correlated with BMI in glucagon stimulation tests (GST). Despite a standard method to assess EIS, GST can produce side effects such as nausea. Therefore, we investigated the relationship between EIS and BMI with a simple meal tolerance test (MTT). One-hundred type 2 diabetes mellitus (T2DM) patients (average: age 61, HbA1c 9.2 %, BMI 25.0 kg/m2, duration of DM 11.5 years) subjected to a MTT. We measured serum C-peptide immunoreactivity (CPR) at fasting, and 2 h after a calorie controlled breakfast, and calculated the difference to give ΔCPR. The fasting and postprandial CPR significantly correlated with BMI (R = 0.59, R = 0.48, P < 0.0001, respectively). ΔCPR also significantly correlated to BMI (R = 0.34, P < 0.001). HbA1c had a significant negative association of ΔCPR (R = −0.38, P < 0.0005). The optimal cut-off level of BMI to predict ΔCPR <1.0 was 20.5 kg/m2 using the ROC curve (sensitivity 83 %, specificity 88 %). Using multiple regression analysis, we examined influence factors of ΔCPR; the significant standard partial regression coefficients were: BMI 0.254, insulin use −0.237, HbA1c -0.358 (P < 0.05). The HbA1c level in BMI > 25.0 kg/m2 was significantly higher in patients with 1.0 < ΔCPR <2.0 than patients with ΔCPR > = 2.0 (10.0 % vs. 8.5 %). The BMI significantly correlated with EIS ability in a MTT, and is a simple index to predict EIS. The insulin secretion ability diminished in patients with BMI <20 kg/m2, and BMI > 25 kg/m2 but high HbA1c > 10 %.
Literature
1.
go back to reference DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667–87.PubMedCrossRef DeFronzo RA. Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes. 1988;37:667–87.PubMedCrossRef
2.
go back to reference Kadowaki T, Miyake Y, Kajinuma H. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26:44–9.PubMedCrossRef Kadowaki T, Miyake Y, Kajinuma H. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26:44–9.PubMedCrossRef
3.
go back to reference Kadowaki T, Yoshinaga H. Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan. Diabetes Res Clin Pract. 1994;24:123–7.CrossRef Kadowaki T, Yoshinaga H. Risk factors for the development of non-insulin-dependent diabetes mellitus (NIDDM) in Japan. Diabetes Res Clin Pract. 1994;24:123–7.CrossRef
4.
go back to reference Faber OK, Binder C. C-peptide response to glucagons, a test for the residual b-cell function in diabetes mellitus. Diabetes. 1977;26:605–10.PubMedCrossRef Faber OK, Binder C. C-peptide response to glucagons, a test for the residual b-cell function in diabetes mellitus. Diabetes. 1977;26:605–10.PubMedCrossRef
5.
go back to reference Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, et al. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care. 2008;31:1966–71.PubMedCentralPubMedCrossRef Greenbaum CJ, Mandrup-Poulsen T, McGee PF, Battelino T, Haastert B, Ludvigsson J, et al. Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care. 2008;31:1966–71.PubMedCentralPubMedCrossRef
6.
go back to reference Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract. 2008;82:353–8.PubMedCrossRef Funakoshi S, Fujimoto S, Hamasaki A, Fujiwara H, Fujita Y, Ikeda K, et al. Analysis of factors influencing pancreatic beta-cell function in Japanese patients with type 2 diabetes: association with body mass index and duration of diabetic exposure. Diabetes Res Clin Pract. 2008;82:353–8.PubMedCrossRef
7.
go back to reference American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30 Suppl 1:S42–7.CrossRef American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2007;30 Suppl 1:S42–7.CrossRef
8.
go back to reference The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010;53:450–67. The Committee of Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. J Jpn Diabetes Soc 2010;53:450–67.
10.
go back to reference Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.PubMedCentralPubMedCrossRef Perkins NJ, Schisterman EF. The inconsistency of “optimal” cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163:670–5.PubMedCentralPubMedCrossRef
11.
go back to reference Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. b-cell deficit and increased b-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.PubMedCrossRef Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC. b-cell deficit and increased b-cell apoptosis in humans with type 2 diabetes. Diabetes. 2003;52:102–10.PubMedCrossRef
12.
go back to reference Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003;88:2300–8.PubMedCrossRef Yoon KH, Ko SH, Cho JH, Lee JM, Ahn YB, Song KH, et al. Selective beta-cell loss and alpha-cell expansion in patients with type 2 diabetes mellitus in Korea. J Clin Endocrinol Metab. 2003;88:2300–8.PubMedCrossRef
13.
go back to reference Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 2001;50:590–3.PubMedCrossRef Kim DJ, Lee MS, Kim KW, Lee MK. Insulin secretory dysfunction and insulin resistance in the pathogenesis of Korean type 2 diabetes mellitus. Metabolism. 2001;50:590–3.PubMedCrossRef
14.
go back to reference Lu WG, Pipeleers DG, Kloppel G, Bouwens L. Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets. Virchows Arch. 1996;429:205–11.PubMed Lu WG, Pipeleers DG, Kloppel G, Bouwens L. Comparative immunocytochemical study of MHC class II expression in human donor pancreas and isolated islets. Virchows Arch. 1996;429:205–11.PubMed
15.
go back to reference Besser RE, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT. The impact of insulin administration during the mixed meal tolerance test. Diabet Med. 2012;29:1279–84.PubMedCrossRef Besser RE, Jones AG, McDonald TJ, Shields BM, Knight BA, Hattersley AT. The impact of insulin administration during the mixed meal tolerance test. Diabet Med. 2012;29:1279–84.PubMedCrossRef
16.
go back to reference Meier JJ, Pennartz C, Schenker N, Menge BA, Schmidt WE, Heise T, et al. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy. Diabetes Obes Metab. 2013;15:258–63.PubMedCrossRef Meier JJ, Pennartz C, Schenker N, Menge BA, Schmidt WE, Heise T, et al. Hyperglycaemia is associated with impaired pulsatile insulin secretion: effect of basal insulin therapy. Diabetes Obes Metab. 2013;15:258–63.PubMedCrossRef
17.
go back to reference Hovorka R, Albarrak A, Chassin L, Luzio SD, Playle R, Owens DR. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes. Diabet Med. 2001;18:797–802.PubMedCrossRef Hovorka R, Albarrak A, Chassin L, Luzio SD, Playle R, Owens DR. Relationship between beta-cell responsiveness and fasting plasma glucose in Caucasian subjects with newly presenting type 2 diabetes. Diabet Med. 2001;18:797–802.PubMedCrossRef
18.
go back to reference Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 1992;15:442–55.PubMedCrossRef Leahy JL, Bonner-Weir S, Weir GC. Beta-cell dysfunction induced by chronic hyperglycemia. Current ideas on mechanism of impaired glucose-induced insulin secretion. Diabetes Care. 1992;15:442–55.PubMedCrossRef
19.
go back to reference Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 1985;28:119–21.PubMedCrossRef Unger RH, Grundy S. Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 1985;28:119–21.PubMedCrossRef
Metadata
Title
Endogenous insulin secretion ability in meal tolerance test correlated with body mass index (BMI) in Japanese type 2 diabetes patients
Authors
Tsuyoshi Ohkura
Youhei Fujioka
Shoichiro Izawa
Keisuke Sumi
Naoya Yamamoto
Hideki Shiochi
Kazuhiko Matsuzawa
Hiroshi Kinoshita
Hiroko Ohkura
Masahiko Kato
Shin-Ichi Taniguchi
Kazuhiro Yamamoto
Publication date
01-12-2014
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 4/2014
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-013-0181-8

Other articles of this Issue 4/2014

International Journal of Diabetes in Developing Countries 4/2014 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.